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INDIVIDUALS WITH MULTIPLE SCLEROSIS PRESENT 
LOWER VELOCITY AND SIMILAR CADENCE TO 
HEALTHY PEERS 
 
PESSOAS COM ESCLEROSE MÚLTIPLA APRESENTAM BAIXA 
VELOCIDADE NA MARCHA E MESMA CADÊNCIA QUE PESSOAS 
SAUDÁVEIS 
 
Abstract: Purpose: To investigate velocity and cadence in people with multiple 
sclerosis (MS) submitted to different walking tasks, and to compare the results 
with those found in healthy control peers. Methods: One hundred thirty-three 
participants, sixty-six with MS and sixty-seven without MS, were enrolled in this 
study. Subjects were divided into three groups according to clinical condition 
and disease severity. Group 1 was formed by forty mild stage subjects with MS, 
group 2 was composed by twenty-six moderate stage subjects with MS and 
group 3 was formed by sixty-seven healthy control peers. Participants’ velocity 
(meters/second) and cadence (steps/minute) were assessed during a walking 
test, using a two-dimensional gait system. The tests were applied with motor and 
cognitive distractors. Statistical procedures involved repeated measures 
analyses of variance to test main effects for group and task. Significance was 
set at 5%. Results: The results showed velocity as being task- and group- 
dependent, id est, the impact on the outcome differs according to clinical 
condition (p=0.001; power of 99.9%) and to task complexity (p=0.001; power of 
99.9%).  Cadence, differently, showed to be task- but not group-dependent. 
That is, complex tasks affect cadence in both groups (p=0.001; power of 99.9%) 
but on a similar basis (p=0.290; power of 26.8%). Conclusion: The results suggest 
that in MS clinical condition and disease severity impact gait velocity on a 
bigger extend than cadence. Further studies should be carried out to investigate 
the adaptation mechanisms that occur in MS during challenging mobility 
situations. 
Keywords: Multiple Sclerosis; Mobility limitation; Task Performance and Analysis; 
Multitasking behavior; Neurologic Gait Disorders. 
Resumo: Objetivo: Investigar velocidade e cadência em pessoas com esclerose 
múltipla (EM) submetidas a diferentes tarefas de caminhada e comparar 
resultados com os encontrados em controles saudáveis. Métodos: 133 
participantes, 66 com e 67 sem EM, foram incluídos neste estudo. Os indivíduos 
foram divididos em três grupos de acordo com o quadro clínico e a gravidade 
da doença. O grupo 1 foi formado por 40 indivíduos com EM estágio leve, o 
grupo 2 foi composto por 26 indivíduos com EM estágio moderado e o grupo 3 
foi formado por 67 sujeitos controles saudáveis. A velocidade dos participantes 
(m/s) e cadência (passos/minuto) foram avaliados durante um teste de 
caminhada, usando um sistema de marcha bidimensional. Os testes foram 
aplicados com distratores motores e cognitivos. Para a análise estatística 
utilizou-se o teste de análise de variância de medidas repetidas, sob 
significância de 5%. Resultados: Os resultados mostraram que velocidade 
depende da tarefa e do grupo, isto é, o impacto difere de acordo com a 
condição clínica (p=0,001; poder: 99,9%) e tarefa (p=0,001; poder: 99,9%). A 
cadência mostrou-se dependente da tarefa, mas não do grupo. Ou seja, 
tarefas complexas afetam a cadência em ambos os grupos (p=0,001; poder: 
99,9%), mas de forma semelhante (p=0,290; poder: 26,8%). Conclusão: Os 
resultados sugerem que a condição clínica e a gravidade da EM afetam a 
velocidade da marcha em uma extensão maior que a cadência. Novos 
estudos devem ser realizados para investigar os mecanismos de adaptação 
que ocorrem na EM durante situações desafiadoras. 
Palavras-chave: Esclerose múltipla; Limitação de mobilidade; Análise de 
desempenho de tarefas; Comportamento multitarefa; Transtornos neurológicos 
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INTRODUCTION 
Multiple sclerosis (MS) is an autoimmune 
condition that causes demyelination in the white 
matter of the central nervous system. The most 
common form of the disease is relapsing-
remitting, characterized by the combination of 
neurological dysfunctions with remission 
episodes1. The disease progression is associated 
with the intensity of cellular apoptosis and with 
the presence of autoreactive T cells. 
Lymphocytes activations end up affecting the 
reorganization of the myelin sheath, causing 
several symptoms to patients2,3.  
Patients with MS suffer a wide range of 
motor and non-motor symptoms that impact 
subjects’ everyday life. Previous studies reported 
postural instabilities, cognitive decline, balance 
problems, lack of coordination, and depression 
in MS4-7. While such symptoms are commonly 
affected during human aging, in MS the 
individual seems to present these symptoms 
early8,9. 
The impact that complex tasks has on the 
mobility of subjects with MS has been well 
studied. Fritz and colleagues10, for example, 
found that patients with MS suffer a maladaptive 
plasticity during movement that ends up 
activating complementary areas of the brain – 
namely the supplementary motor area. When 
complex tasks are associated with cognitive 
challenges, Etemadi11 reported that patients 
with MS are subject to a greater imbalance and 
to an increasing risk of falls. 
In this study, authors performed an in-
depth analysis about how disease severity 
impact mobility in subjects with MS. The 
differential of this study upon the others is that 
most studies focus on tasks performance and in 
this study authors focused on the impact of 
disease severity upon the task. 
The hypothesis raised by the authors was 
that dealing with complex situations constitutes 
an increasing risk for subjects with MS, causing 
pitfalls in decision making processes. Authors 
expected that participants in the advanced 
stages of the disease would show a decreasing 
velocity (meters per second) and an increasing 
cadence (steps per minute) during mobility tasks, 
reinforcing a conflict between cognitive and 
motor demands. 
METHODS 
Individuals with MS were recruited from 
the Multiple Sclerosis Outpatient Center at the 
hospital complex of the Federal University of 
Mato Grosso do Sul. Community dwelling 
controls were selected according to 
sociodemographic measures of the MS group, 
ensuring homogeneity for age and sex. This 
research was conducted in accordance to the 
Declaration of Helsinki and its protocol was 
approved by the institutional Ethics Committee 
(Protocol 2111.925;CAAE: 13647513.8.0000.0021). 
All participants provided written consent prior 
the assessments. 
The inclusion criteria involved participants 
older than 18 years, diagnosed as having 
relapsing-remitting MS, all sedentary, and with 
disease severity 0 to 6 according the Kurtzke 
Expanded Disability Status Scale (EDSS)12. The 
exclusion criteria involved participants with 
cognitive decline, individuals that were unable 
to walk independently, and those who had 
history or were using psychotropic or 
antipsychotic drugs. Subjects that could not 
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Participants who met the inclusion criteria 
were divided into three groups: G1, G2, and G3. 
Groups were allocated according to 
participants’ disease severity and clinical 
condition. Sample size calculation showed the 
need of a minimum of 78 participants, 26 per 
group. Such analysis was grounded with the 
delimitation of a 5% alpha error, a statistical 
power of 95% and an effect size of 0.413. 
In this study, the groups were formed by 
40 mild stage subjects with MS (G1), 26 moderate 
stage individuals with MS (G2), and 67 healthy 
control peers (G3). Participants’ demographic 
and clinical characteristics are detailed in table 
1. 
 
Table 1. Demographics and clinical characteristics of the groups 
Variables G1 G2 G3 p 
Sample size 40 26 67 0.001 
Sex (Male:Female) 28:12 20:6 49:18 0.825 
Age (years) 37.0 ± 12.7 43.0 ± 12.0 39.4 ± 12.5 0.163 
Disease severity (points) 1.60 ± 0.8 4.3 ± 1.2 --- 0.001 
Data are expressed in mean ± standard deviation. Inferential analyses involved chi-squared test for sample size 
and sex, the one-way ANOVA for age, and the independent student t-test for disease severity 
 
To investigate the impact of disease 
severity on mobility in MS, authors assessed 
subjects’ cadence and velocity during a walking 
test. Cadence (steps/minute) and velocity 
(meters/second) were measured using a two-
dimensional gait system, during a getting-up, 
walking, returning and seating task14,15. The task 
should have to be done as fast as possible, 
involving three conditions that required different 
capabilities: a single task, a motor dual task 
(carrying a glass of water), and a cognitive dual 
task (counting progressive odd numbers). The   
order of the tasks was random for each 
participant. The assessments involved two 
trained researchers, and the measures were 
done in a private and quiet evaluation room.  
The tasks were administered after a full 
explanation of the procedures. Participants were 
advised to observe task priority (walking without 
spilling the contents of the cup and walking and 
maintaining the accuracy of the count) but they 
should conclude the test as fast as possible, 




Descriptive statistics were used to 
calculate means and standard deviations. 
Shapiro-Wilk and Levene’s tests confirmed 
parametric assumptions for normality and 
homogeneity of variances. Thus, repeated 
measures ANOVA was applied to estimate main 
effects of mobility on velocity and cadence. 
Outliers were excluded prior the inferential 
analyses16. The level of significance was set at 
5%. 
 
Oliveira, RT; Brandão, PMF; Charro, PD; Christofoletti, G. 
 
6 Revista Movimenta 2021; 14(1):3-9 
RESULTS 
One hundred and fifty subjects were 
recruited in this study (~92% above the minimal 
sample size needed). Due to eligibility criteria, 
seventeen participants were excluded. Reasons 
for the exclusions were other types of MS than 
relapsing-remitting (n=6), participants with 
cognitive decline (n=5), patients unable to walk 
independently (n=4) and subjects aged under 
18 years (n=2). The final sample was composed 
by one hundred thirty-three participants, sixty-six 
with MS and sixty-seven healthy control peers.  
The variability of gait cadence and 
velocity in the MS and control groups is shown in 
Table 2.
Table 2. Variability of cadence (steps/minute) and velocity (meters/sec) according to each 
mobility condition. 




















76.4 ± 16.9  0.290 26.8 0.001  99.9 0.029 75.1 




72.0 ± 15.5 




78.6 ± 14.3 
Velocity, 
meters/sec 




0.5 ± 0.2 0.001 99.9 0.001 99.9 0.420 30.8 




0.4 ± 0.2 




0.6 ± 0.1 
Data are expressed in mean ± standard deviation. Inferential analyses involved repeated measures analysis of variance for 




Physical decline in MS burden patients 
and families. The situation gets worse with the 
progression of the disease, when subjects end up 
losing their independence on everyday 
activities17,18. In this scenario, this study 
investigated how velocity and cadence 
behavior in face of disease progression. 
The use of a functional test to assess 
mobility showed to be useful for the 
achievements proposed. As alternating 
directions occurs in most of the movements 
done in everyday tasks, authors forced subjects’ 
to deal with pitfalls during the tasks to see how 
efficient the response of the central nervous 
system is in individuals with MS19. 
The findings confirmed the authors’ 
hypothesis when showed velocity as being task- 
and group- specific, id est, the impact on the 
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outcome differs according to clinical condition 
and to task complexity. Differently, analyses 
involving cadence went against authors’ 
hypothesis. While it was expected to find 
interference on group and task, results 
confirmed cadence as being task- but not 
group-dependent. This finding suggests that 
complex tasks affect cadence in subjects with 
and without MS on a similar basis. An in-depth 
analysis of the predictors that affect mobility 
during single and dual tasks is important not only 
to understand the physiological mechanisms 
involved on mobility in MS, but it is also crucial 
when proposing new therapies to such 
population. 
Cadence and velocity represent, along 
other spatial and temporal parameters, 
predictors directly related to patients’ risk of falls. 
In the present study the authors believed that 
participants would end up decreasing the 
velocity and increasing their cadence as a way 
to guarantee a smaller and safer support base. 
The velocity indeed decreased as harder was 
the tasks performed (as expected) – 
corroborating previous publications6,20,21. The 
cadence, differently, increased during motor 
dual task (as expected) and decreased during 
cognitive dual tasks. This pattern suggests that 
patients with MS present more difficulties in 
processing motor dual tasks than cognitive dual 
tasks. 
The similar pattern of cadence seen in 
participants with and without MS is a point that 
deserves reflection and complementary 
analyses. As detailed before, authors expected 
to find a higher cadence in MS subjects due to a 
neurophysiological response that indirectly 
would have decrease the step length and would 
have made support bases smaller and safer for 
the patient. The similar pattern between groups 
can either suggest that the tasks were not as 
demanding to impact cadence, or it can imply 
that such predictor is not affected on mild to 
moderate subjects with MS. Further studies with 
more challenging situations are necessary to 
confirm such premise.  
The findings of this study on velocity and 
cadence shall be useful for health care 
professionals. As stated by Muratori and 
colleagues22, gait parameters are a sensitive 
biomarker of disease progression and they must 
guide professionals during analysis of 
interventions’ effectiveness.  
It is worth mentioning that the data are 
grounded by a representative sample size, which 
has exceeded in more than 70.5% the minimum 
amount of subjects required. The strong power of 
the statistical analyses (seen in table 2) gives the 
authors the support to affirm that the type-1 and 
type-2 errors were controlled, ensuring that no 




Although the current study provides 
important information on mobility in individuals 
with MS, it has some limitations that need to be 
considered. First, it is important to emphasize that 
only participants with mild to moderate degrees 
of compromise resulting from MS were enrolled in 
this study. The exclusion of subjects with a severe 
compromise was because independence of 
locomotion is unusual in advanced stages of the 
disease23. In addition, none of the participants 
had cognitive impairment – although this aspect 
is common in MS24. The reason for excluding 
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subjects with cognitive impairment was because 
the cognitive decline could make the 
understanding of the tasks difficult. The results, 
thus, may not be generalizable to people with 




The results suggest that, in MS, clinical 
condition and disease severity impact gait 
velocity on a bigger extend than cadence. 
Considering that one of the goals of health care 
professionals is to promote functional 
independence and improve patients’ quality of 
life, the results may support professionals in 
planning new therapies. 
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